مرور Volume 1, Issue 1 بر اساس عنوان
در حال نمایش موارد 1 - 5 از 5
-
Assessment of Anti-streptokinase Antibody in Patients with Heart Diseases and Normal Subjects
(Shiraz Institute for Cancer Research, 2004-06-01)Background: Streptokinase, which is injected intravenously with a standard dose of 1.5 MIU, is the most widely used thrombolytic agent around the world. What is so important about this bioproduct is the level of ...
-
Detection of Rheumatoid Factors in Sera and Biopsy Lesions of Vitiligo Patients
(Shiraz Institute for Cancer Research, 2004-06-01)Background: Vitiligo is a dermatological disorder of unknown etiology with a common incidence in southern Iran. Presence of autoantibodies to melanocyte antigens suggested an autoimmune basis of the disease. ...
-
Identification and Characterization of Leishmania spp. in Impreession Smears of Patients with Cutaneous Leishmaniasis
(Shiraz Institute for Cancer Research, 2004-06-01)Background: Monoclonal antibodies have been employed extensively for the identification of Leishmania species, development of diagnostic tests and in the characterization of defined leishmanial antigens. ...
-
Immunological Basis of Neurological Diseases
(Shiraz Institute for Cancer Research, 2004-06-01)Clinical neurology has been traditionally considered as an academic speciality in which the specialist regurgitates his/her knowledge of neurology without being able to do much for the patient. This attitude is no longer ...
-
Th1 and Th2 Cytokine Gene Polymorphism in Iranian Patients with Chronic Myelogenous Leukemia
(Shiraz Institute for Cancer Research, 2004-06-01)Background:It has been hypothesized that genetic factors other than histocompatibility disparity may play a role in predisposition to developing Chronic Myelogenous Leukemia (CML). In this regard, Th1 and Th2 cytokines ...



